Calendar of Events

In January, pharmacists will be given access to publicly funded diphtheria-tetanus-acellular pertussis combined vaccine (dTap) to vaccinate pregnant women. This session will help you to understand diphtheria, tetanus and pertussis and the relevant recommendations for dTap vaccination in pregnancy.

In January, pharmacists will be given access to publicly funded pneumococcal vaccine to vaccinate people 65 years of age and older. This session will help you to understand pneumococcal disease and relevant recommendations for pneumococcal vaccination.

This four-module course provides an overview of the requirements for Additional Prescribing Authority (APA). - Module 1: General Overview - Module 2: Case Requirements - Module 3: Case Assessment - Module 4: Application Form

This course will provide an overview of the policies and procedures for pharmacists participating in the delivery of publicly funded influenza vaccine for the 2019-2020 season

RxA and ACP hosted an opioid focused program aimed at helping pharmacists understand how to engage with a patient during an opioid assessment. This session describes a patient’s story.

This harm reduction focused program, presented jointly by RxA and ACP, is aimed at helping pharmacists learn about collaboration strategies to assist in the building and maintenance of professional relationships with patients requiring harm reduction measures and how to foster interdisciplinary collaboration.

This harm reduction focused program is aimed at helping pharmacists learn about the ethical implications of harm reduction and how to identify implications for practice.

RxA pharmacist members are invited to attend: "Pneumococcal Vaccine Update – “Debunking the Mis-Information”